Anna Van Acker is president and managing director at Merck Canada Inc. She has almost 30 years of wide-ranging experience at Merck in important leadership positions across multiple therapeutic areas and geographies. Ms. Van Acker is dedicated to improving and saving patients' lives through ensuring access, affordability and appropriate use of Merck's innovative product portfolio. Van Acker is a member of the board of directors of Innovative Medicines Canada. She also sits on the board of directors of Montréal InVivo.
Following last month’s Women Deliver conference, Merck for Mothers' Mary-Ann Etiebet and Merck Canada's Anna Van Acker share their vision for advancing the private sector’s commitment to ensuring gender equality is the norm.